Reviews examine blood–brain barrier-conscious nanomedicines for glioblastoma treatment
Glioblastoma remains one of the most formidable challenges in modern cancer medicine. The aggressive brain tumor is the most common...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Glioblastoma remains one of the most formidable challenges in modern cancer medicine. The aggressive brain tumor is the most common...
Cancer biology is increasingly revealing that tumors are not defined solely by rapidly dividing malignant cells. They are dynamic ecosystems...
Ovarian cancer has long been associated with a striking preference for the omentum, a fatty apron of tissue that hangs...
Researchers at the University of California, San Francisco, have developed a laboratory-based method that could help predict how individual breast...
Melanoma patients may carry clues in their blood that reveal how well their immune systems are responding to immunotherapy, according...
A new study published in Nature Communications has identified measurable molecular changes in human blood that may help explain how...
Researchers at the USC Viterbi School of Engineering and the Keck School of Medicine of USC have developed a genetic...
SCOTTSDALE, Ariz. — Aug. 11, 2026 — Physicians at HonorHealth Research Institute have begun testing a personalized dendritic-cell vaccine designed...
Immunotherapy has changed the treatment landscape for cancer, but its benefits remain unevenly distributed among patients with gastric cancer. Immune...
A new review published in Oncoscience argues that the next generation of CAR-T therapy for solid tumors will depend less...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine